382 related articles for article (PubMed ID: 33767450)
1. Single-cell transcriptomic analyses provide insights into the developmental origins of neuroblastoma.
Jansky S; Sharma AK; Körber V; Quintero A; Toprak UH; Wecht EM; Gartlgruber M; Greco A; Chomsky E; Grünewald TGP; Henrich KO; Tanay A; Herrmann C; Höfer T; Westermann F
Nat Genet; 2021 May; 53(5):683-693. PubMed ID: 33767450
[TBL] [Abstract][Full Text] [Related]
2. Single-Cell Characterization of Malignant Phenotypes and Developmental Trajectories of Adrenal Neuroblastoma.
Dong R; Yang R; Zhan Y; Lai HD; Ye CJ; Yao XY; Luo WQ; Cheng XM; Miao JJ; Wang JF; Liu BH; Liu XQ; Xie LL; Li Y; Zhang M; Chen L; Song WC; Qian W; Gao WQ; Tang YH; Shen CY; Jiang W; Chen G; Yao W; Dong KR; Xiao XM; Zheng S; Li K; Wang J
Cancer Cell; 2020 Nov; 38(5):716-733.e6. PubMed ID: 32946775
[TBL] [Abstract][Full Text] [Related]
3. Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes.
De Preter K; Vandesompele J; Heimann P; Yigit N; Beckman S; Schramm A; Eggert A; Stallings RL; Benoit Y; Renard M; De Paepe A; Laureys G; Påhlman S; Speleman F
Genome Biol; 2006; 7(9):R84. PubMed ID: 16989664
[TBL] [Abstract][Full Text] [Related]
4. Single-cell atlas of developing murine adrenal gland reveals relation of Schwann cell precursor signature to neuroblastoma phenotype.
Hanemaaijer ES; Margaritis T; Sanders K; Bos FL; Candelli T; Al-Saati H; van Noesel MM; Meyer-Wentrup FAG; van de Wetering M; Holstege FCP; Clevers H
Proc Natl Acad Sci U S A; 2021 Feb; 118(5):. PubMed ID: 33500353
[TBL] [Abstract][Full Text] [Related]
5. Lin28B and Let-7 in the Control of Sympathetic Neurogenesis and Neuroblastoma Development.
Hennchen M; Stubbusch J; Abarchan-El Makhfi I; Kramer M; Deller T; Pierre-Eugene C; Janoueix-Lerosey I; Delattre O; Ernsberger U; Schulte JB; Rohrer H
J Neurosci; 2015 Dec; 35(50):16531-44. PubMed ID: 26674877
[TBL] [Abstract][Full Text] [Related]
6. Single-nuclei transcriptomes from human adrenal gland reveal distinct cellular identities of low and high-risk neuroblastoma tumors.
Bedoya-Reina OC; Li W; Arceo M; Plescher M; Bullova P; Pui H; Kaucka M; Kharchenko P; Martinsson T; Holmberg J; Adameyko I; Deng Q; Larsson C; Juhlin CC; Kogner P; Schlisio S
Nat Commun; 2021 Sep; 12(1):5309. PubMed ID: 34493726
[TBL] [Abstract][Full Text] [Related]
7. Single-cell transcriptomics of human embryos identifies multiple sympathoblast lineages with potential implications for neuroblastoma origin.
Kameneva P; Artemov AV; Kastriti ME; Faure L; Olsen TK; Otte J; Erickson A; Semsch B; Andersson ER; Ratz M; Frisén J; Tischler AS; de Krijger RR; Bouderlique T; Akkuratova N; Vorontsova M; Gusev O; Fried K; Sundström E; Mei S; Kogner P; Baryawno N; Kharchenko PV; Adameyko I
Nat Genet; 2021 May; 53(5):694-706. PubMed ID: 33833454
[TBL] [Abstract][Full Text] [Related]
8. The basic helix-loop-helix transcription factor dHAND, a marker gene for the developing human sympathetic nervous system, is expressed in both high- and low-stage neuroblastomas.
Gestblom C; Grynfeld A; Ora I; Ortoft E; Larsson C; Axelson H; Sandstedt B; Cserjesi P; Olson EN; Påhlman S
Lab Invest; 1999 Jan; 79(1):67-79. PubMed ID: 9952112
[TBL] [Abstract][Full Text] [Related]
9. Transcription factor activating protein 2 beta (TFAP2B) mediates noradrenergic neuronal differentiation in neuroblastoma.
Ikram F; Ackermann S; Kahlert Y; Volland R; Roels F; Engesser A; Hertwig F; Kocak H; Hero B; Dreidax D; Henrich KO; Berthold F; Nürnberg P; Westermann F; Fischer M
Mol Oncol; 2016 Feb; 10(2):344-59. PubMed ID: 26598443
[TBL] [Abstract][Full Text] [Related]
10. Neuroblast differentiation during development and in neuroblastoma requires KIF1Bβ-mediated transport of TRKA.
Fell SM; Li S; Wallis K; Kock A; Surova O; Rraklli V; Höfig CS; Li W; Mittag J; Henriksson MA; Kenchappa RS; Holmberg J; Kogner P; Schlisio S
Genes Dev; 2017 May; 31(10):1036-1053. PubMed ID: 28637693
[TBL] [Abstract][Full Text] [Related]
11. Proliferation and Survival of Embryonic Sympathetic Neuroblasts by MYCN and Activated ALK Signaling.
Kramer M; Ribeiro D; Arsenian-Henriksson M; Deller T; Rohrer H
J Neurosci; 2016 Oct; 36(40):10425-10439. PubMed ID: 27707976
[TBL] [Abstract][Full Text] [Related]
12. Association of high-risk neuroblastoma classification based on expression profiles with differentiation and metabolism.
Kimura S; Sekiguchi M; Watanabe K; Hiwatarai M; Seki M; Yoshida K; Isobe T; Shiozawa Y; Suzuki H; Hoshino N; Hayashi Y; Oka A; Miyano S; Ogawa S; Takita J
PLoS One; 2021; 16(1):e0245526. PubMed ID: 33465163
[TBL] [Abstract][Full Text] [Related]
13. HIF2A and IGF2 expression correlates in human neuroblastoma cells and normal immature sympathetic neuroblasts.
Mohlin S; Hamidian A; Påhlman S
Neoplasia; 2013 Mar; 15(3):328-34. PubMed ID: 23479510
[TBL] [Abstract][Full Text] [Related]
14. Differences in Genomic Profiles and Outcomes Between Thoracic and Adrenal Neuroblastoma.
Oldridge DA; Truong B; Russ D; DuBois SG; Vaksman Z; Mosse YP; Diskin SJ; Maris JM; Matthay KK
J Natl Cancer Inst; 2019 Nov; 111(11):1192-1201. PubMed ID: 30793172
[TBL] [Abstract][Full Text] [Related]
15. 11q Deletion or ALK Activity Curbs DLG2 Expression to Maintain an Undifferentiated State in Neuroblastoma.
Siaw JT; Javanmardi N; Van den Eynden J; Lind DE; Fransson S; Martinez-Monleon A; Djos A; Sjöberg RM; Östensson M; Carén H; Trøen G; Beiske K; Berbegall AP; Noguera R; Lai WY; Kogner P; Palmer RH; Hallberg B; Martinsson T
Cell Rep; 2020 Sep; 32(12):108171. PubMed ID: 32966799
[TBL] [Abstract][Full Text] [Related]
16. Incorporating genomic, transcriptomic and clinical data: a prognostic and stem cell-like MYC and PRC imbalance in high-risk neuroblastoma.
Yang XH; Tang F; Shin J; Cunningham JM
BMC Syst Biol; 2017 Oct; 11(Suppl 5):92. PubMed ID: 28984200
[TBL] [Abstract][Full Text] [Related]
17. Functional MYCN signature predicts outcome of neuroblastoma irrespective of MYCN amplification.
Valentijn LJ; Koster J; Haneveld F; Aissa RA; van Sluis P; Broekmans ME; Molenaar JJ; van Nes J; Versteeg R
Proc Natl Acad Sci U S A; 2012 Nov; 109(47):19190-5. PubMed ID: 23091029
[TBL] [Abstract][Full Text] [Related]
18. Origin and initiation mechanisms of neuroblastoma.
Tsubota S; Kadomatsu K
Cell Tissue Res; 2018 May; 372(2):211-221. PubMed ID: 29445860
[TBL] [Abstract][Full Text] [Related]
19. MAX to MYCN intracellular ratio drives the aggressive phenotype and clinical outcome of high risk neuroblastoma.
Ferrucci F; Ciaccio R; Monticelli S; Pigini P; di Giacomo S; Purgato S; Erriquez D; Bernardoni R; Norris M; Haber M; Milazzo G; Perini G
Biochim Biophys Acta Gene Regul Mech; 2018 Mar; 1861(3):235-245. PubMed ID: 29408445
[TBL] [Abstract][Full Text] [Related]
20. p19-INK4d inhibits neuroblastoma cell growth, induces differentiation and is hypermethylated and downregulated in MYCN-amplified neuroblastomas.
Dreidax D; Bannert S; Henrich KO; Schröder C; Bender S; Oakes CC; Lindner S; Schulte JH; Duffy D; Schwarzl T; Saadati M; Ehemann V; Benner A; Pfister S; Fischer M; Westermann F
Hum Mol Genet; 2014 Dec; 23(25):6826-37. PubMed ID: 25104850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
